| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420802A1 Increased solubility flavanolignan preparations |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420790A1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420774A1 Preparation and diabetic use of gibberellins |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420769A2 Lipid profile modulation with steroids |
| 05/26/2004 | EP1420745A2 Use of r-nsaid compounds for anti-hiv treatment |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1313499A4 Method for treating the central nervous system by administration of igf structural analogs |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1187605A4 Non-malignant disease treatment with ras antagonists |
| 05/26/2004 | EP1165104B1 Lactobacillus parcasei strain capable of preventing diarrhoea |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | EP0729360B1 Linear and cyclic peptides for treatment or prevention of crohn's disease and/or ulcerative colitis |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499927A Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 05/26/2004 | CN1498892A Extract of general glycoside in picrorhiza rhizome as well as preparation method and application |
| 05/26/2004 | CN1498652A Compsn. for health care of teeth and curing oral disease |
| 05/26/2004 | CN1498651A Medicaton for treating celiaca and its prepn. method |
| 05/26/2004 | CN1498649A Method for preparing 'Yueju' capsule and method for controlling quality |
| 05/26/2004 | CN1498642A Oral liquid of Chinese traditional medicine for treating wean indigestion |
| 05/26/2004 | CN1498636A Combined medication for treating gastric disease |
| 05/26/2004 | CN1498620A Compsn. containing oligose |
| 05/26/2004 | CN1498619A Hydrochloric 'Azasiqiong' tablet and its preparing method |
| 05/26/2004 | CN1498618A Injection of hydrochloric 'Azasiqiong' powder and its prepn. method |
| 05/26/2004 | CN1498613A Combination of 5-HT3 receptor antagonist of spraying administration for treating nasal mucosa |
| 05/26/2004 | CN1498610A Asynchronous method for health of mouth cavity daily |
| 05/26/2004 | CN1151250C Recombinant adenovirus for preventing baby's diarrhea |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1150939C Traditional Chinese medicine prepn. for eliminating mass and relieving dyspepsia |
| 05/26/2004 | CN1150937C Chinese medicine composition with functions of regulating blood-liquid and curing chemical liver injury |
| 05/26/2004 | CN1150936C Honey cream for treating hepatitis B |
| 05/26/2004 | CN1150929C Malian granule for clearing away liver fever |
| 05/26/2004 | CN1150927C Stomatopathy and throat disease treating health care medicine and its production process |
| 05/26/2004 | CN1150926C Medicine for treating hepatitis B and cirrhosis |
| 05/26/2004 | CN1150923C Medicine for treating stomatocase |
| 05/26/2004 | CN1150919C Paste for eradicating liver disease and preparing method |
| 05/26/2004 | CN1150918C Medicine containing active components of Panax japonicum foot and preparing process |
| 05/26/2004 | CN1150913C Chinese patent drug for treating peridentitis |
| 05/26/2004 | CN1150910C Instant bee pollen and its preparing process |
| 05/26/2004 | CN1150908C Prodn. method of seahorse powder capsule |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/26/2004 | CN1150902C Prescription of preparing moxapride citrate |
| 05/26/2004 | CN1150889C Oral Micro-emulsion composition of silybin |
| 05/26/2004 | CN1150883C Process for preparing gargle |
| 05/26/2004 | CN1150882C Health-care liquid of oral cavity and its preparing process |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740667 Antimicrobial agent |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/25/2004 | US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 05/21/2004 | WO2004042076A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041303A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | WO2004041291A1 High affinity receptors for helicobacter pylori and use thereof |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041245A2 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |